Cargando…
The value of patient-reported outcomes in lung cancer clinical trials
Autores principales: | Pompili, Cecilia, Feldman, Jill |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801276/ https://www.ncbi.nlm.nih.gov/pubmed/36590719 http://dx.doi.org/10.1016/j.xjon.2022.10.001 |
Ejemplares similares
-
Eurolung risk score is associated with long-term survival after curative resection for lung cancer
por: Brunelli, Alessandro, et al.
Publicado: (2021) -
Germline mutations in high penetrance genes are associated with worse clinical outcomes in patients with non–small cell lung cancer
por: Krantz, Seth B., et al.
Publicado: (2022) -
Treatment quality and outcomes vary with hospital burden of uninsured and Medicaid patients with cancer in early non–small cell lung cancer
por: Muslim, Zaid, et al.
Publicado: (2022) -
Impact of robotic access on outcomes after lung cancer surgery in France: Analysis from the Epithor database
por: Madelaine, Leslie, et al.
Publicado: (2023) -
Trends of utilization and perioperative outcomes of robotic and video-assisted thoracoscopic surgery in patients with lung cancer undergoing minimally invasive resection in the United States
por: Alwatari, Yahya, et al.
Publicado: (2022)